ctrl K

Watchlist Price Alert

Prometheus Biosciences In... (RXDX)

NASDAQ: RXDX · Real-Time Price · USD

199.92

0.18 (0.09%)

At close: Jun 15, 2023, 8:00 PM

Prometheus Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	292.42M	257.25M	54.2M	4.45M	24.34M	46.38M
Short-Term Investments	403.33M	n/a	n/a	n/a	83.64M	85.42M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	971K	971K	1.73M	n/a	26.79M	41.18M
Receivables	1.03M	1.08M	1.09M	n/a	n/a	n/a
Inventory	-1.03M	-1.08M	n/a	n/a	n/a	n/a
Other Current Assets	12.4M	8.13M	n/a	n/a	3.87M	4.41M
Total Current Assets	708.15M	265.38M	57.46M	37.53M	111.85M	136.21M
Property-Plant & Equipment	31.65M	1.45M	447K	6.81M	6.27M	18.76M
Goodwill & Intangibles	n/a	n/a	n/a	6.14M	n/a	n/a
Total Long-Term Assets	32.62M	2.42M	2.18M	12.95M	33.06M	59.94M
Total Assets	740.77M	267.8M	59.63M	50.48M	144.91M	196.15M
Account Payables	762K	1.15M	958K	1.4M	n/a	3.83M
Deferred Revenue	1.3M	3.67M	1.88M	1.54M	n/a	n/a
Short-Term Debt	3.22M	11.59M	12.35M	7.26M	n/a	6.89M
Other Current Liabilities	17.54M	35K	67K	21.67M	17.52M	14.04M
Total Current Liabilities	22.82M	16.44M	15.26M	31.88M	17.52M	24.76M
Long-Term Debt	26.32M	n/a	7.4M	n/a	31.12M	23.24M
Other Long-Term Liabilities	41.99M	n/a	129.92M	55.58M	1.51M	12.16M
Total Long-Term Liabilities	41.99M	16.2M	141.92M	55.58M	32.63M	35.41M
Total Liabilities	64.81M	32.65M	157.17M	87.45M	50.14M	60.16M
Total Debt	29.54M	n/a	7.4M	n/a	114.75M	30.13M
Common Stock	5K	4K	n/a	n/a	4K	3K
Retained Earnings	-331.09M	-189.34M	-99.15M	-37.45M	-251.66M	-148.02M
Comprehensive Income	-429K	-267.8M	n/a	n/a	-3.52M	-2.67M
Shareholders Equity	675.97M	235.16M	-97.54M	-36.97M	94.77M	135.99M
Total Investments	403.33M	n/a	n/a	n/a	83.64M	85.42M